
2020 Virtual DIA Editor’s Take – OM1
Richard Gliklich, M.D., CEO, OM1
Richard Gliklich, M.D., CEO, OM1, discusses the special considerations and challenges around quality in clinical data in terms of regulatory considerations as well as how AI and machine learning factor into R&D today and in the future.
For more information please visit www.om1.com.